Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand Use of RELISTORby the European Medicines Agency
April 22, 2014 at 07:02 AM EDT
Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that the submission to the ...